Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alzheimer Disease
Research reveals promising approach to treatment of Alzheimer disease
November 18th, 2005
Saint Louis University research shows a new class of drugs may hold promise in treating brain chemical problems such as Alzheimer disease, says the principal investigator of research published in an early on-line version of Peptides. "We found that we can develop antisense - which is a molecular compound - to cross the blood brain barrier enough to alter brain function. This can have a profound effect on treating diseases that occur because there is too much or too little of a certain kind of protein in the brain," says William A. Banks, MD, professor of geriatrics and pharmacological and physiological sciences at Saint Louis University and principal...
Source: Drug Week (2005-11-18)
|
